Max Oscherwitz

5PUBLICATIONS
8CO-AUTHORS
AutoimmunityEquity and trusts lawAllergyCheminformatics and quantitative structure-activity relationshipsMedical biochemistry - lipids
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 07, 2024
Case report: Iatrogenic Kaposi sarcoma secondary to Janus kinase and tumor necrosis factor-alpha inhibitors in rheumatoid arthritis.

Angel Kevin Garza-Elizondo, Max Oscherwitz, Valeria Cervantes-Ramirez

|Jun 26, 2024
Effects of Private Equity on Dermatologic Quality of Patient Care.

Max E Oscherwitz, Brandon M Godinich, Raj H Patel

|Apr 06, 2024
Should systemic corticosteroids be relatively contraindicated in granuloma annulare?

Max E Oscherwitz, Matthew L Hrin, Zachary J Neuberg

|Feb 09, 2024
Necrotic skin ulcerations caused by xylazine in people who inject intravenous drugs.

Max E Oscherwitz, John Trinidad, Steven T Chen

|Jan 18, 2024
Evaluation of pentoxifylline in the treatment of necrobiosis lipoidica: outcomes in 10 patients.

Matthew L Hrin, Max Oscherwitz, Joseph L Jorizzo

Pageof 1